Shanghai Shen Lian Biomedical Corporation (SHA:688098)

SHA:688098 Revenue

Shanghai Shen Lian Biomedical had revenue of 78.74M CNY in the quarter ending March 31, 2025, a decrease of -10.58%. This brings the company's revenue in the last twelve months to 294.10M, down -4.42% year-over-year. In the year 2024, Shanghai Shen Lian Biomedical had annual revenue of 303.41M with 0.64% growth.

• Revenue (ttm): 294.10M
• Revenue Growth: -4.42%
• P/S Ratio: 8.22
• Revenue / Employee: 752.17K
• Employees: 391
• Market Cap: 2.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	303.41M	1.93M	0.64%
Dec 31, 2023	301.49M	-27.11M	-8.25%
Dec 31, 2022	328.59M	-29.83M	-8.32%
Dec 31, 2021	358.43M	20.70M	6.13%
Dec 31, 2020	337.73M	83.92M	33.07%